Back

Differential and lasting gene expression changes in circulating CD8 T cells in chronic HCV infection with cirrhosis and related insights on the role of Hedgehog signaling

Li, J.; Vranjkovic, A.; Read, D.; Delaney, S. P.; Stanford, W. L.; Cooper, C. L.; Crawley, A. M.

2023-09-21 immunology
10.1101/2023.09.20.557725 bioRxiv
Show abstract

The impact of chronic hepatic infection on antigen non-specific immune cells in circulation is not well understood and may influence long term health. We reported lasting global hyperfunction of circulating CD8 T cells in HCV-infected individuals with cirrhosis. Whether gene expression patterns in bulk CD8 T cells are associated with the severity of liver fibrosis in HCV infection is not known. RNA sequencing of blood CD8 T cells from treatment-naive, HCV-infected individuals with minimal (Metavir F0-1 [≤] 7.0 kPa) or advanced fibrosis or cirrhosis (F4 [≥] 12.5 kPa), before and after direct-acting antiviral therapy, was performed. Principal component analyses determined robust differences in over 350 genes expressed by CD8 T cells from HCV-infected individuals with minimal or advanced fibrosis and data suggests this remains relatively stable after viral clearance. Gene ontology analyses identified disaggregated gene expression related to cellular metabolism, including upregulated phospholipase, phosphatidyl-choline/inositol activity and second-messenger-mediated signaling, while genes in pathways associated with nuclear processes, RNA transport and cytoskeletal dynamics were reduced. Gene Set Enrichment Analysis identified decreased expression of genes regulated by the cMyc and E2f transcription factors in cirrhotics, compared to the minimal fibrosis group, as well as reduced expression of genes linked to oxidative phosphorylation, mTOR signaling, and more. Upregulated gene sets in cirrhotics included IFN-, -{gamma}, TGF-{beta} response genes, apoptosis and apical surface pathways, among others. The hedgehog (Hh) signaling pathway was the top featured gene set upregulated in cirrhotics. Inhibition of Hh signaling with cyclopamine ablated CD8 T cell IFN-{gamma} production, suggesting its involvement in hyperfunction. This is the first analysis of bulk CD8 T cell gene expression profiles in HCV infection in the context of liver fibrosis severity, and suggests cirrhosis significantly reprograms the CD8 T cell pool. The novel finding of increased Hh signaling in cirrhosis may contribute to generalized CD8 T cell hyperfunction observed in chronic HCV infection. Understanding the lasting nature of immune cell dysfunction may help mitigate remaining clinical challenges after HCV clearance and more generally, improve long term outcomes for individuals with severe liver disease.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal of Hepatology
18 papers in training set
Top 0.1%
23.2%
2
Hepatology
18 papers in training set
Top 0.1%
12.9%
3
Gastroenterology
40 papers in training set
Top 0.4%
5.0%
4
Gut
36 papers in training set
Top 0.2%
3.7%
5
JCI Insight
241 papers in training set
Top 1%
3.7%
6
eLife
5422 papers in training set
Top 24%
3.7%
50% of probability mass above
7
Journal of Virology
456 papers in training set
Top 1%
3.3%
8
PLOS Pathogens
721 papers in training set
Top 4%
3.2%
9
mBio
750 papers in training set
Top 6%
2.7%
10
Nature Communications
4913 papers in training set
Top 45%
2.4%
11
Hepatology Communications
21 papers in training set
Top 0.2%
2.1%
12
Cell Reports
1338 papers in training set
Top 22%
1.9%
13
Frontiers in Immunology
586 papers in training set
Top 3%
1.9%
14
Scientific Reports
3102 papers in training set
Top 56%
1.7%
15
Cell Reports Medicine
140 papers in training set
Top 3%
1.7%
16
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.4%
1.5%
17
PLOS ONE
4510 papers in training set
Top 58%
1.4%
18
Viruses
318 papers in training set
Top 4%
1.3%
19
mSphere
281 papers in training set
Top 5%
1.0%
20
Wellcome Open Research
57 papers in training set
Top 2%
0.9%
21
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
22
Immunity
58 papers in training set
Top 4%
0.8%
23
Clinical and Experimental Immunology
12 papers in training set
Top 0.1%
0.7%
24
EMBO reports
136 papers in training set
Top 6%
0.7%
25
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
26
Human Genetics and Genomics Advances
70 papers in training set
Top 0.8%
0.7%
27
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.7%
28
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 1%
0.7%
29
Stem Cells Translational Medicine
11 papers in training set
Top 0.2%
0.7%
30
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%